淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4832人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997867, encodeId=08c9199e867d0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2017 ASH】伊布替尼可有效控制老年慢性淋巴细胞白血病进展并改善患者生活质量, objectType=article, longId=123152, objectId=40001231522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40001231522f, replyNumber=0, likeNumber=28, createdTime=2018-01-29, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40001231522f, moduleTitle=【2017 ASH】伊布替尼可有效控制老年慢性淋巴细胞白血病进展并改善患者生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40001231522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997866, encodeId=abdf199e8668b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案, objectType=article, longId=123151, objectId=925712315133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925712315133, replyNumber=0, likeNumber=25, createdTime=2018-05-03, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925712315133, moduleTitle=【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925712315133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997886, encodeId=6034199e88612, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）, objectType=article, longId=133577, objectId=a18a1335e7e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18a1335e7e7, replyNumber=0, likeNumber=24, createdTime=2018-06-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18a1335e7e7, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18a1335e7e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997896, encodeId=ec2f199e89658, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, objectType=article, longId=137617, objectId=231413e617e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231413e617e4, replyNumber=0, likeNumber=55, createdTime=2018-07-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231413e617e4, moduleTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231413e617e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997881, encodeId=3737199e8817a, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：在Ph样急性淋巴细胞白血病中发现一新的与酪氨酸激酶抑制剂耐药性直接相关的PDGFRB突变, objectType=article, longId=129567, objectId=985a12956e3b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=985a12956e3b, replyNumber=0, likeNumber=58, createdTime=2018-07-26, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=985a12956e3b, moduleTitle=Blood：在Ph样急性淋巴细胞白血病中发现一新的与酪氨酸激酶抑制剂耐药性直接相关的PDGFRB突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=985a12956e3b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997853, encodeId=617d199e85322, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, objectType=article, longId=114676, objectId=4ab01146e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab01146e693, replyNumber=0, likeNumber=58, createdTime=2018-07-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab01146e693, moduleTitle=Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ab01146e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997895, encodeId=6698199e89521, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告, objectType=article, longId=137175, objectId=ab6213e1753d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6213e1753d, replyNumber=0, likeNumber=92, createdTime=2018-08-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6213e1753d, moduleTitle=儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6213e1753d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997861, encodeId=e467199e86181, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2017 ASH】伊布替尼联合利妥昔单抗用于慢性淋巴细胞白血病, objectType=article, longId=122418, objectId=f1f41224182c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1f41224182c, replyNumber=0, likeNumber=42, createdTime=2018-04-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1f41224182c, moduleTitle=【2017 ASH】伊布替尼联合利妥昔单抗用于慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1f41224182c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997898, encodeId=7559199e89813, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：CD19/CD3双特异性抗体为慢性淋巴细胞白血病患者，特别是依鲁替尼耐药的患者，带来新的希望, objectType=article, longId=137882, objectId=562213e882e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=562213e882e1, replyNumber=0, likeNumber=56, createdTime=2018-07-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=562213e882e1, moduleTitle=Blood：CD19/CD3双特异性抗体为慢性淋巴细胞白血病患者，特别是依鲁替尼耐药的患者，带来新的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=562213e882e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997902, encodeId=e452199e90293, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=中国慢性淋巴细胞白血病 /小淋巴细胞淋巴瘤的诊断与治疗指南（2018年版）, objectType=article, longId=141938, objectId=8e4e14193801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e4e14193801, replyNumber=0, likeNumber=25, createdTime=2019-06-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e4e14193801, moduleTitle=中国慢性淋巴细胞白血病 /小淋巴细胞淋巴瘤的诊断与治疗指南（2018年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e4e14193801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997846, encodeId=5b32199e846b1, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：RUNX1竟然在急性淋巴细胞白血病中具有致癌性。, objectType=article, longId=108214, objectId=a0b910821459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b910821459, replyNumber=0, likeNumber=81, createdTime=2018-01-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b910821459, moduleTitle=Blood：RUNX1竟然在急性淋巴细胞白血病中具有致癌性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0b910821459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997859, encodeId=fb8b199e85957, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V5）, objectType=article, longId=119204, objectId=26f311920462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26f311920462, replyNumber=0, likeNumber=51, createdTime=2017-11-19, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26f311920462, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26f311920462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997894, encodeId=70c5199e89401, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JCO：IKZF1plus 结合微小残留病——儿童急性B前体淋巴细胞白血病预后评估更精准, objectType=article, longId=136718, objectId=4cde136e18dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cde136e18dc, replyNumber=0, likeNumber=73, createdTime=2018-09-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cde136e18dc, moduleTitle=JCO：IKZF1plus 结合微小残留病——儿童急性B前体淋巴细胞白血病预后评估更精准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cde136e18dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997836, encodeId=e217199e8363c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JCO：起源于早期前体T细胞的急性淋巴细胞白血病患者应如何治疗？, objectType=article, longId=102189, objectId=e5fc10218922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5fc10218922, replyNumber=0, likeNumber=67, createdTime=2017-10-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5fc10218922, moduleTitle=JCO：起源于早期前体T细胞的急性淋巴细胞白血病患者应如何治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5fc10218922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997848, encodeId=839a199e848f9, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V2）, objectType=article, longId=112894, objectId=a34b1128944e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34b1128944e, replyNumber=0, likeNumber=27, createdTime=2018-08-02, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34b1128944e, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34b1128944e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997875, encodeId=086f199e8750f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：微环境诱导的CD44v6突变可促进慢性淋巴细胞白血病的早期进展。, objectType=article, longId=127191, objectId=ab8612e19151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab8612e19151, replyNumber=0, likeNumber=110, createdTime=2018-05-05, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab8612e19151, moduleTitle=Blood：微环境诱导的CD44v6突变可促进慢性淋巴细胞白血病的早期进展。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab8612e19151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997845, encodeId=176c199e845e7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？, objectType=article, longId=107218, objectId=590b10e21832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=590b10e21832, replyNumber=0, likeNumber=65, createdTime=2018-06-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=590b10e21832, moduleTitle=Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=590b10e21832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997890, encodeId=3653199e890b8, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=中国儿童急性淋巴细胞白血病长期生存率接近国际发达国家水平, objectType=article, longId=134622, objectId=2a4013462282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a4013462282, replyNumber=0, likeNumber=58, createdTime=2018-08-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a4013462282, moduleTitle=中国儿童急性淋巴细胞白血病长期生存率接近国际发达国家水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a4013462282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997879, encodeId=77de199e879ae, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：采用依鲁替尼治疗的慢性淋巴细胞白血病患者，早发性侵袭性真菌感染的相关风险, objectType=article, longId=128884, objectId=875e128884c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875e128884c3, replyNumber=0, likeNumber=55, createdTime=2018-11-22, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875e128884c3, moduleTitle=Blood：采用依鲁替尼治疗的慢性淋巴细胞白血病患者，早发性侵袭性真菌感染的相关风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875e128884c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997835, encodeId=b5e2199e83516, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：VEGF,急性淋巴细胞白血病侵入中枢神经系统的新机制, objectType=article, longId=100451, objectId=9a7e1004511c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a7e1004511c, replyNumber=0, likeNumber=81, createdTime=2017-07-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a7e1004511c, moduleTitle=Blood：VEGF,急性淋巴细胞白血病侵入中枢神经系统的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a7e1004511c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2017 ASH】伊布替尼可有效控制老年慢性淋巴细胞白血病进展并改善患者生活质量

2018-01-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案

2018-05-03

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）

2018-06-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！

2018-07-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：在Ph样急性淋巴细胞白血病中发现一新的与酪氨酸激酶抑制剂耐药性直接相关的PDGFRB突变

2018-07-26

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：首次发现BCL-2抑制剂Venetoclax用于T幼淋巴细胞白血病患者可获得临床反应。

2018-07-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

儿童高白细胞性B淋巴细胞白血病治疗中继发血小板增多症1例报告

2018-08-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2017 ASH】伊布替尼联合利妥昔单抗用于慢性淋巴细胞白血病

2018-04-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：CD19/CD3双特异性抗体为慢性淋巴细胞白血病患者，特别是依鲁替尼耐药的患者，带来新的希望

2018-07-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

中国慢性淋巴细胞白血病 /小淋巴细胞淋巴瘤的诊断与治疗指南（2018年版）

2019-06-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：RUNX1竟然在急性淋巴细胞白血病中具有致癌性。

2018-01-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：急性淋巴细胞白血病（2017.V5）

2017-11-19

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JCO：IKZF1plus 结合微小残留病——儿童急性B前体淋巴细胞白血病预后评估更精准

2018-09-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JCO：起源于早期前体T细胞的急性淋巴细胞白血病患者应如何治疗？

2017-10-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：急性淋巴细胞白血病（2017.V2）

2018-08-02

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：微环境诱导的CD44v6突变可促进慢性淋巴细胞白血病的早期进展。

2018-05-05

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？

2018-06-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

中国儿童急性淋巴细胞白血病长期生存率接近国际发达国家水平

2018-08-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：采用依鲁替尼治疗的慢性淋巴细胞白血病患者，早发性侵袭性真菌感染的相关风险

2018-11-22

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：VEGF,急性淋巴细胞白血病侵入中枢神经系统的新机制

2017-07-12

科室
- - 订阅+
  - 更多科室
工具
服务